CDIO

Cardio Diagnostics Holdings, Inc. (CDIO) Risks & Opportunities Analysis (2026)

Invetso Score: 6.2/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Risks

Score: 5.4 (Moderate)

Negative interest coverage and modest net debt versus EBITDA increase refinancing sensitivity, but CDIO’s low debt-to-equity and far stronger liquidity than smaller peers reduce near-term balance-sheet pressure.

Days sales outstanding near 99 and a very long cash conversion cycle imply working-capital drag, which can constrain cash generation versus peers with faster collections and tighter operating cycles.

Extremely high payables days support liquidity today, yet they can signal supplier dependence and limit flexibility if vendors tighten terms, especially versus better-capitalized peers.

Absent positive free-cash-flow visibility, CDIO remains more exposed than profitable peers to demand softness or delayed collections, which could pressure funding capacity over the next 1–5 years.

Opportunities

Score:

A current ratio above 17 provides unusually strong liquidity, giving CDIO more operating runway than most micro-cap peers during periods of uneven demand or capital-market volatility.

Low debt-to-equity and modest net debt versus EBITDA leave CDIO better positioned than levered peers to preserve flexibility if growth opportunities or refinancing needs emerge.

Negative cash conversion cycle, driven by extended payables, can support near-term cash preservation relative to peers with cash tied up in inventory or receivables.

If collections improve, CDIO could convert its liquidity cushion into stronger funding capacity faster than peers with tighter balance sheets and weaker working-capital buffers.

Overall Score

Score:

CDIO’s exceptional liquidity and low leverage support peer-relative resilience, but weak coverage, slow collections, and working-capital dependence keep forward positioning only moderately attractive.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Cardio Diagnostics Holdings, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →